| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10219959 | European Urology | 2018 | 9 Pages |
Abstract
Active surveillance is an option for kidney masses, even if they are malignant. Beyond knowing whether the mass is benign or cancer, it is important to know whether or not it is an aggressive tumor. This study presents tumor size-specific and sex-specific estimates of the probability of cancer overall and aggressive cancer among patients with a kidney mass in order to aid with initial decision-making.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bimal Bhindi, R. Houston Thompson, Christine M. Lohse, Ross J. Mason, Igor Frank, Brian A. Costello, Aaron M. Potretzke, Robert P. Hartman, Theodora A. Potretzke, Stephen A. Boorjian, John C. Cheville, Bradley C. Leibovich,